To strengthen effector functions of CD27, single-positive NK cells might be particularly relevant for MS, since CD27 single-positive NK cells and their human CD56bright NK cell counterparts are the dominant intrathecal and lymph node NK cell population [46]. This evidence concerns the gene CD27 and myeloid sarcoma.